RecruitingNCT01660984

Natural History Study of Children and Adults With Medullary Thyroid Cancer

Longitudinal Assessment and Natural History Study of Children and Adults With MEN2A or MEN2B With or Without Medullary Thyroid Carcinoma


Sponsor

National Cancer Institute (NCI)

Enrollment

259 participants

Start Date

Jul 30, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

Background: \- Medullary thyroid cancer (MTC) is a rare cancer of the thyroid gland. In children and adults, it is often part of a condition called Multiple Endocrine Neoplasia 2 (MEN2). MEN2 is usually caused by a genetic mutation, and it can cause a number of problems in addition to MTC. These problems include adrenal gland tumors, hormone changes, and problems with the bones and other organs. Not much is known about how MTC develops over time, especially in people with MEN2. Researchers want to study MTC in children and adults and see how it affects their growth and development. Objectives: \- To study how medullary thyroid cancer affects children and adults over time. Eligibility: \- Children and adults who have medullary thyroid cancer. Design: * Participants will be screened with a brief physical exam and medical history. Blood and tissue samples will be collected to see whether participants have the MEN2 genetic mutation. * Treatment will not be provided as part of this study. However, participants will be receiving standard care for MTC. They may be eligible for other clinical trials at the National Institutes of Health. * Participants will have regular study visits every 6 to 12 months to evaluate their MTC and any treatment. Blood tests, imaging studies, and other tests may be performed as needed to monitor the disease. * Participants and their parents/guardians will also complete questionnaires about their health and emotions during the study.


Eligibility

Min Age: 4 Months

Plain Language Summary

Simplified for easier understanding

This study is following children and adults with medullary thyroid cancer (MTC) — a type of thyroid cancer that can run in families and is associated with genetic mutations — to better understand how the disease progresses and to identify better treatment approaches. **You may be eligible if...** - You have been diagnosed with medullary thyroid cancer, confirmed by lab pathology - You have been diagnosed with MEN2A or MEN2B (inherited syndromes that significantly increase the risk of thyroid and other cancers), even if you do not yet have thyroid cancer - You are able to travel to the NIH for evaluations - You or your legal guardian (if you are under 18) can provide written informed consent **You may NOT be eligible if...** - You are unable to travel to the NIH for study visits - You or your guardian is unable to provide informed consent - You do not have confirmed MTC, MEN2A, or MEN2B Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01660984


Related Trials